BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 103 filers reported holding BIOSCRIP INC in Q4 2017. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $29,000 | -76.6% | 14,277 | -58.8% | 0.01% | -71.7% |
Q4 2018 | $124,000 | +29.2% | 34,667 | +5.2% | 0.05% | +142.1% |
Q4 2017 | $96,000 | -85.7% | 32,962 | -86.5% | 0.02% | -80.6% |
Q3 2017 | $672,000 | -1.0% | 244,264 | -2.3% | 0.10% | +21.0% |
Q2 2017 | $679,000 | +51.6% | 249,964 | -5.1% | 0.08% | +84.1% |
Q1 2017 | $448,000 | +56.6% | 263,464 | -4.1% | 0.04% | +83.3% |
Q4 2016 | $286,000 | -72.8% | 274,764 | -24.5% | 0.02% | -76.0% |
Q3 2016 | $1,051,000 | +1197.5% | 363,726 | +1898.5% | 0.10% | +900.0% |
Q1 2015 | $81,000 | – | 18,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |